Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Feb 28, 2018 11:12pm
341 Views
Post# 27641486

RE:Alstrom data delayed

RE:Alstrom data delayedReally?  While PL absolutely has an established MO of seemingly following a negative news release with a positive one...i suggest you  re confirm with your reliable source,  because last time i checked the rules around selective disclosure of material inside information is unequivocally illegal....  and while this management team has pulled some really stupid shite...i doubt they would actually stoop to that.

gosh I wish these guys were more forthcoming with updates and information,  it would
go a long way to mitigating this rumour mongering thats become
so rampant thru this short
attack.

for all the incredible clinical and ip value build progress,
this is unnecessarilly difficult...particularly of they actually have broken the fibrosis code
Bullboard Posts